CD8A and neoplasm: To elucidate the functions of CD4+ T cells, CD8+ T cells and NK cells within the context of the anti‐tumor response elicited by FAST, we utilized specific depletion antibodies to monitor the anti‐tumor efficacy of FAST following the depletion of the respective immune cells (Figure 2C–G).